7alpha-Hydroxy-4-cholesten-3-one

7alpha-hydroxy-4-cholesten-3-one is a lipid of Sterol Lipids (ST) class. The related lipids are Steroids and Cholestenones.

Cross Reference

Introduction

To understand associated biological information of 7alpha-Hydroxy-4-cholesten-3-one, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 7alpha-Hydroxy-4-cholesten-3-one?

There are no associated biomedical information in the current reference collection.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7alpha-Hydroxy-4-cholesten-3-one

MeSH term MeSH ID Detail
Cholestasis D002779 23 associated lipids
Xanthomatosis, Cerebrotendinous D019294 14 associated lipids
Total 2

PubChem Associated disorders and diseases

What pathways are associated with 7alpha-Hydroxy-4-cholesten-3-one

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 7alpha-Hydroxy-4-cholesten-3-one?

There are no associated biomedical information in the current reference collection.

What functions are associated with 7alpha-Hydroxy-4-cholesten-3-one?

There are no associated biomedical information in the current reference collection.

What lipids are associated with 7alpha-Hydroxy-4-cholesten-3-one?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 7alpha-Hydroxy-4-cholesten-3-one?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with 7alpha-Hydroxy-4-cholesten-3-one?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 7alpha-Hydroxy-4-cholesten-3-one

Download all related citations
Per page 10 20 50 100 | Total 146
Authors Title Published Journal PubMed Link
Donato LJ et al. Description of analytical method and clinical utility of measuring serum 7-alpha-hydroxy-4-cholesten-3-one (7aC4) by mass spectrometry. 2018 Clin. Biochem. pmid:29051033
Othman RA et al. Thyroid Hormone Status in Sitosterolemia Is Modified by Ezetimibe. 2017 J. Pediatr. pmid:28625503
Mast N et al. Cytochrome P450 27A1 Deficiency and Regional Differences in Brain Sterol Metabolism Cause Preferential Cholestanol Accumulation in the Cerebellum. 2017 J. Biol. Chem. pmid:28190002
Wang Y et al. Barley β-glucan reduces blood cholesterol levels via interrupting bile acid metabolism. 2017 Br. J. Nutr. pmid:29115200
Zweers SJ et al. Prolonged fibroblast growth factor 19 response in patients with primary sclerosing cholangitis after an oral chenodeoxycholic acid challenge. 2017 Hepatol Int pmid:27696157
Mignarri A et al. Evaluation of cholesterol metabolism in cerebrotendinous xanthomatosis. 2016 J. Inherit. Metab. Dis. pmid:26153518
Blahová T et al. The effect of colesevelam treatment on bile acid and lipid metabolism and glycemic control in healthy men. 2016 Physiol Res pmid:27539104
Zhang L et al. Impaired Bile Acid Homeostasis in Children with Severe Acute Malnutrition. 2016 PLoS ONE pmid:27163928
Vlachova M et al. Diurnal variation in cholesterol 7α-hydroxylase activity is determined by the -203A>C polymorphism of the CYP7A1 gene. 2016 Croat. Med. J. pmid:27106353
Graffner H et al. The ileal bile acid transporter inhibitor A4250 decreases serum bile acids by interrupting the enterohepatic circulation. 2016 Aliment. Pharmacol. Ther. pmid:26527417
Chen M et al. The rate-determining steps of aldo-keto reductases (AKRs), a study on human steroid 5β-reductase (AKR1D1). 2015 Chem. Biol. Interact. pmid:25500266
Rudling M et al. Specific inhibition of bile acid transport alters plasma lipids and GLP-1. 2015 BMC Cardiovasc Disord pmid:26197999
Camilleri M et al. Effect of colesevelam on faecal bile acids and bowel functions in diarrhoea-predominant irritable bowel syndrome. 2015 Aliment. Pharmacol. Ther. pmid:25594801
Camilleri M et al. Genetic variation in GPBAR1 predisposes to quantitative changes in colonic transit and bile acid excretion. 2014 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:25012842
Vlaardingerbroek H et al. New generation lipid emulsions prevent PNALD in chronic parenterally fed preterm pigs. 2014 J. Lipid Res. pmid:24478031
Luo J et al. A nontumorigenic variant of FGF19 treats cholestatic liver diseases. 2014 Sci Transl Med pmid:25080475
Amano Y et al. Combinational effects of farnesoid X receptor antagonist and statin on plasma lipid levels and low-density lipoprotein clearance in guinea pigs. 2014 Life Sci. pmid:24805868
Bertolotti M et al. Age-associated alterations in cholesterol homeostasis: evidence from a cross-sectional study in a Northern Italy population. 2014 Clin Interv Aging pmid:24669190
Pattni SS et al. Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention. 2013 Aliment. Pharmacol. Ther. pmid:23981126
Freudenberg F et al. Serum 7-alpha-hydroxy-4-cholesten-3-one as a marker for bile acid loss in children. 2013 J. Pediatr. pmid:23968740
Hirsova P et al. Cholestatic effect of epigallocatechin gallate in rats is mediated via decreased expression of Mrp2. 2013 Toxicology pmid:23146761
Ogawa S et al. An efficient synthesis of 7α,12α-dihydroxy-4-cholesten-3-one and its biological precursor 7α-hydroxy-4-cholesten-3-one: Key intermediates in bile acid biosynthesis. 2013 Steroids pmid:23707572
Marschall HU et al. Combined rifampicin and ursodeoxycholic acid treatment does not amplify rifampicin effects on hepatic detoxification and transport systems in humans. 2012 Digestion pmid:22964716
Xiang X et al. Gender, but not CYP7A1 or SLCO1B1 polymorphism, affects the fasting plasma concentrations of bile acids in human beings. 2012 Basic Clin. Pharmacol. Toxicol. pmid:21902813
Wong BS et al. Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea. 2012 Clin. Gastroenterol. Hepatol. pmid:22610000
Steiner C et al. Lipoprotein distribution and serum concentrations of 7α-hydroxy-4-cholesten-3-one and bile acids: effects of monogenic disturbances in high-density lipoprotein metabolism. 2012 Clin. Sci. pmid:22010943
Yang Q et al. Dietary fish oil increases fat absorption and fecal bile acid content without altering bile acid synthesis in 20-d-old weanling rats following massive ileocecal resection. 2012 Pediatr. Res. pmid:22447320
Lundåsen T et al. Inhibition of intestinal bile acid transporter Slc10a2 improves triglyceride metabolism and normalizes elevated plasma glucose levels in mice. 2012 PLoS ONE pmid:22662222
Li T and Chiang JY Bile Acid signaling in liver metabolism and diseases. 2012 J Lipids pmid:21991404
Matysik S et al. Monitoring of 7α-hydroxy-4-cholesten-3-one during therapy of cerebrotendinous xanthomatosis: a case report. 2011 Chem. Phys. Lipids pmid:21679699
Matysik S et al. Bile acid signaling after an oral glucose tolerance test. 2011 Chem. Phys. Lipids pmid:21679700
Steiner C et al. Bile acid metabolites in serum: intraindividual variation and associations with coronary heart disease, metabolic syndrome and diabetes mellitus. 2011 PLoS ONE pmid:22110577
Gälman C et al. Pronounced variation in bile acid synthesis in humans is related to gender, hypertriglyceridaemia and circulating levels of fibroblast growth factor 19. 2011 J. Intern. Med. pmid:22003820
Wong BS et al. Effects of A3309, an ileal bile acid transporter inhibitor, on colonic transit and symptoms in females with functional constipation. 2011 Am. J. Gastroenterol. pmid:21876564
Johnston I et al. New insights into bile acid malabsorption. 2011 Curr Gastroenterol Rep pmid:21805078
Barbara G et al. The immune system in irritable bowel syndrome. 2011 J Neurogastroenterol Motil pmid:22148103
Brydon WG et al. An evaluation of the use of serum 7-alpha-hydroxycholestenone as a diagnostic test of bile acid malabsorption causing watery diarrhea. 2011 Can. J. Gastroenterol. pmid:21766092
Mindnich R et al. The effect of disease associated point mutations on 5β-reductase (AKR1D1) enzyme function. 2011 Chem. Biol. Interact. pmid:21185810
Lenicek M et al. Bile acid malabsorption in inflammatory bowel disease: assessment by serum markers. 2011 Inflamm. Bowel Dis. pmid:21058331
Kaddurah-Daouk R et al. Enteric microbiome metabolites correlate with response to simvastatin treatment. 2011 PLoS ONE pmid:22022402
Rao AS et al. Chenodeoxycholate in females with irritable bowel syndrome-constipation: a pharmacodynamic and pharmacogenetic analysis. 2010 Gastroenterology pmid:20691689
Steiner C et al. Quantification of the 15 major human bile acids and their precursor 7α-hydroxy-4-cholesten-3-one in serum by liquid chromatography-tandem mass spectrometry. 2010 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:20869337
Walters JR Defining primary bile acid diarrhea: making the diagnosis and recognizing the disorder. 2010 Expert Rev Gastroenterol Hepatol pmid:20932141
DeBarber AE et al. ESI-MS/MS quantification of 7alpha-hydroxy-4-cholesten-3-one facilitates rapid, convenient diagnostic testing for cerebrotendinous xanthomatosis. 2010 Clin. Chim. Acta pmid:19808031
Schreuder TC et al. The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance. 2010 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:20093562
Odunsi-Shiyanbade ST et al. Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function. 2010 Clin. Gastroenterol. Hepatol. pmid:19879973
Björkhem I and Hansson M Cerebrotendinous xanthomatosis: an inborn error in bile acid synthesis with defined mutations but still a challenge. 2010 Biochem. Biophys. Res. Commun. pmid:20494109
BÃ¥vner A et al. On the mechanism of accumulation of cholestanol in the brain of mice with a disruption of sterol 27-hydroxylase. 2010 J. Lipid Res. pmid:20511491
Kovár J et al. Regulation of diurnal variation of cholesterol 7alpha-hydroxylase (CYP7A1) activity in healthy subjects. 2010 Physiol Res pmid:19537927
Drury JE et al. Characterization of disease-related 5beta-reductase (AKR1D1) mutations reveals their potential to cause bile acid deficiency. 2010 J. Biol. Chem. pmid:20522910
Xiang X et al. Effect of SLCO1B1 polymorphism on the plasma concentrations of bile acids and bile acid synthesis marker in humans. 2009 Pharmacogenet. Genomics pmid:19387419
Camilleri M et al. Measurement of serum 7alpha-hydroxy-4-cholesten-3-one (or 7alphaC4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography-tandem mass spectrometry. 2009 Neurogastroenterol. Motil. pmid:19368662
Walters JR et al. A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis. 2009 Clin. Gastroenterol. Hepatol. pmid:19426836
Ung KA et al. Biliary sphincterotomy does not relate to diarrhoea or major changes in bile acid synthesis or plasma lipids. 2009 Scand. J. Gastroenterol. pmid:19811340
Herrera J et al. Fecal bile acid excretion and messenger RNA expression levels of ileal transporters in high risk gallstone patients. 2009 Lipids Health Dis pmid:19995447
Jiang ZY et al. Increased NPC1L1 and ACAT2 expression in the jejunal mucosa from Chinese gallstone patients. 2009 Biochem. Biophys. Res. Commun. pmid:19071091
Bertolotti M et al. Correlation between plasma levels of 7alpha-hydroxy-4-cholesten-3-one and cholesterol 7alpha-hydroxylation rates in vivo in hyperlipidemic patients. 2008 Steroids pmid:18582481
Lenicek M et al. Improved HPLC analysis of serum 7alpha-hydroxycholest-4-en-3-one, a marker of bile acid malabsorption. 2008 Clin. Chem. pmid:18509016
Lenícek M et al. CYP7A1 promoter polymorphism -203A>C affects bile salt synthesis rate in patients after ileal resection. 2008 J. Lipid Res. pmid:18728290
Faucher F et al. The crystal structure of human Delta4-3-ketosteroid 5beta-reductase defines the functional role of the residues of the catalytic tetrad in the steroid double bond reduction mechanism. 2008 Biochemistry pmid:18624455
Dawes LG et al. Decreased bile acid synthesis with total parenteral nutrition. 2007 Am. J. Surg. pmid:17936424
Bertolotti M et al. Age-related changes in bile acid synthesis and hepatic nuclear receptor expression. 2007 Eur. J. Clin. Invest. pmid:17537158
Ellegård L and Andersson H Oat bran rapidly increases bile acid excretion and bile acid synthesis: an ileostomy study. 2007 Eur J Clin Nutr pmid:17251929
Honda A et al. Highly sensitive quantification of 7alpha-hydroxy-4-cholesten-3-one in human serum by LC-ESI-MS/MS. 2007 J. Lipid Res. pmid:17093295
Lövgren-Sandblom A et al. Novel LC-MS/MS method for assay of 7alpha-hydroxy-4-cholesten-3-one in human plasma. Evidence for a significant extrahepatic metabolism. 2007 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:17561450
Ung CY et al. In silico prediction of pregnane X receptor activators by machine learning approaches. 2007 Mol. Pharmacol. pmid:17003167
Panzenboeck U et al. On the mechanism of cerebral accumulation of cholestanol in patients with cerebrotendinous xanthomatosis. 2007 J. Lipid Res. pmid:17325385
Castro J et al. Increased activity of hepatic microsomal triglyceride transfer protein and bile acid synthesis in gallstone disease. 2007 Hepatology pmid:17464999
Bajor A et al. Normal or increased bile acid uptake in isolated mucosa from patients with bile acid malabsorption. 2006 Eur J Gastroenterol Hepatol pmid:16538111
Klass DM et al. Biliary lipids, cholesterol and bile synthesis: different adaptive mechanisms to dietary cholesterol in lean and obese subjects. 2006 Aliment. Pharmacol. Ther. pmid:16573792
Montagnani M et al. Analysis of ileal sodium/bile acid cotransporter and related nuclear receptor genes in a family with multiple cases of idiopathic bile acid malabsorption. 2006 World J. Gastroenterol. pmid:17171805
Bajor A et al. Budesonide treatment is associated with increased bile acid absorption in collagenous colitis. 2006 Aliment. Pharmacol. Ther. pmid:17094773
Bertolotti M et al. Decreased hepatic expression of PPAR-gamma coactivator-1 in cholesterol cholelithiasis. 2006 Eur. J. Clin. Invest. pmid:16506961
Maeda Y et al. Species differences among various rodents in the conversion of 7alpha-hydroxycholesterol in liver microsomes. 2006 Steroids pmid:16455124
Matasconi M et al. Pituitary control of cholesterol metabolism in normal and LDL receptor knock-out mice: effects of hypophysectomy and growth hormone treatment. 2005 Biochim. Biophys. Acta pmid:16185916
Boekschoten MV et al. Coffee oil consumption increases plasma levels of 7alpha-hydroxy-4-cholesten-3-one in humans. 2005 J. Nutr. pmid:15795435
O'Neill FH et al. Comparison of efficacy of plant stanol ester and sterol ester: short-term and longer-term studies. 2005 Am. J. Cardiol. pmid:15992513
Abrahamsson A et al. Common polymorphisms in the CYP7A1 gene do not contribute to variation in rates of bile acid synthesis and plasma LDL cholesterol concentration. 2005 Atherosclerosis pmid:16115473
Gälman C et al. Bile acid synthesis in humans has a rapid diurnal variation that is asynchronous with cholesterol synthesis. 2005 Gastroenterology pmid:16285946
Ellegård L et al. High serum phytosterol levels in short bowel patients on parenteral nutrition support. 2005 Clin Nutr pmid:15896428
Ellegård L et al. Rapeseed oil, olive oil, plant sterols, and cholesterol metabolism: an ileostomy study. 2005 Eur J Clin Nutr pmid:16091765
Honda A et al. Disrupted coordinate regulation of farnesoid X receptor target genes in a patient with cerebrotendinous xanthomatosis. 2005 J. Lipid Res. pmid:15576845
Marschall HU et al. Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans. 2005 Gastroenterology pmid:16083704
Gälman C et al. Bile acid synthesis is increased in Chilean Hispanics with gallstones and in gallstone high-risk Mapuche Indians. 2004 Gastroenterology pmid:14988828
Weinbrenner T et al. Lipoprotein metabolism in patients with anorexia nervosa: a case-control study investigating the mechanisms leading to hypercholesterolaemia. 2004 Br. J. Nutr. pmid:15182399
Lind S et al. Growth hormone induces low-density lipoprotein clearance but not bile acid synthesis in humans. 2004 Arterioscler. Thromb. Vasc. Biol. pmid:14656733
Honda A et al. Significance of plasma 7alpha-hydroxy-4-cholesten-3-one and 27-hydroxycholesterol concentrations as markers for hepatic bile acid synthesis in cholesterol-fed rabbits. 2004 Metab. Clin. Exp. pmid:14681840
Sauter GH et al. Effects of ursodeoxycholic acid on synthesis of cholesterol and bile acids in healthy subjects. 2004 Digestion pmid:15375335
Dussault I et al. Identification of an endogenous ligand that activates pregnane X receptor-mediated sterol clearance. 2003 Proc. Natl. Acad. Sci. U.S.A. pmid:12569201
Ota Y et al. Assay method for mitochondrial sterol 27-hydroxylase with 7alpha-hydroxy-4-cholesten-3-one as a substrate in the rat liver. 2003 J. Lipid Res. pmid:12951370
Gälman C et al. Monitoring hepatic cholesterol 7alpha-hydroxylase activity by assay of the stable bile acid intermediate 7alpha-hydroxy-4-cholesten-3-one in peripheral blood. 2003 J. Lipid Res. pmid:12562858
Hosseinpour F et al. 25-Hydroxylation of vitamin D3 in primary cultures of pig hepatocytes: evidence for a role of both CYP2D25 and CYP27A1. 2003 Biochem. Biophys. Res. Commun. pmid:12670492
Yoshida T et al. Origin of oxysterols in hepatic bile of patients with biliary infection. 2003 Am. J. Gastroenterol. pmid:14572579
Andersson M et al. Oat bran stimulates bile acid synthesis within 8 h as measured by 7alpha-hydroxy-4-cholesten-3-one. 2002 Am. J. Clin. Nutr. pmid:12399287
Maeda Y et al. A comparative study of the conversion of 7-hydroxycholesterol in rabbit, guinea pig, rat, hamster, and chicken. 2002 Steroids pmid:12117617
Gälman C et al. Prolonged stimulation of the adrenals by corticotropin suppresses hepatic low-density lipoprotein and high-density lipoprotein receptors and increases plasma cholesterol. 2002 Endocrinology pmid:11956163
Matsuzaki Y et al. Selective inhibition of CYP27A1 and of chenodeoxycholic acid synthesis in cholestatic hamster liver. 2002 Biochim. Biophys. Acta pmid:12385778
Honda A et al. Differences in hepatic levels of intermediates in bile acid biosynthesis between Cyp27(-/-) mice and CTX. 2001 J. Lipid Res. pmid:11181760
O'Neill FH et al. Determinants of variable response to statin treatment in patients with refractory familial hypercholesterolemia. 2001 Arterioscler. Thromb. Vasc. Biol. pmid:11348882
Tatidis L et al. Cholesterol catabolism in patients with acute myelogenous leukemia and hypocholesterolemia: suppressed levels of a circulating marker for bile acid synthesis. 2001 Cancer Lett. pmid:11463495